Nonsteroidal anti-inflammatory drugs in the treatment of low back pain

References

• BlountBWHartGEhrethJLDescription of the content of army family practiceJ Am Board Fam Pract199361431528452066
   PubMedGoogle Scholar
• KoesBWvan TulderMWOsteloRKim BurtonAWaddellGClinical guidelines for the management of low back pain in primary care: an international comparisonSpine (Phila Pa 1976)200126222504251311707719
   PubMed Web of Science ®Google Scholar
• KoesBWvan TulderMLinCWMacedoLGMcAuleyJMaherCAn updated overview of clinical guidelines for the management of non-specific low back pain in primary careEur Spine J2010192075209420602122
   PubMed Web of Science ®Google Scholar
• Guidelines for the management of acute nonspecific low back pain in primary care Available from: http://www.backpaineurope.org/web/files/WG1_Guidelines.pdf. Accessed December 7, 2011.
   Google Scholar
• PapageorgiouACCroftPRFerrySEstimating the prevalence of low back pain in the general population. Evidence from the South Manchester Back Pain SurveySpine (Phila Pa 1976)199520188918948560337
   PubMed Web of Science ®Google Scholar
• RathmellJPA 50-year-old man with chronic LBPJAMA20082992066207718381566
   PubMed Web of Science ®Google Scholar
• GrotleMBroxJVeierødMClinical course and prognostic factors in acute low back pain: patients consulting primary care for the first timeSpine (Phila Pa 1976)20053097698215834343
   PubMed Web of Science ®Google Scholar
• EldersLBurdorfAPrevalence, incidence, and recurrence of low back pain in scaffolders during a 3-year follow-up studySpine (Phila Pa 1976)200429E101E10615014283
   PubMed Web of Science ®Google Scholar
• EldersLAMVan der BeekAJBurdorfAReturn to work after sickness absence due to back disorders: a systematic review on intervention strategiesInt Arch Occup Environ Health20007333934810963418
   PubMed Web of Science ®Google Scholar
• TousignantMRossignolMGouletLOccupational disability to back pain: application of a theoretical model of work disability using prospective cohorts of manual workersAm J Ind Med20003741042210706753
   PubMed Web of Science ®Google Scholar
• Leboeuf-YdeCBody weight and low back pain: a systematic literature review of 56 journal articles reporting on 65 epidemiologic studiesSpine (Phila Pa 1976)20002522623710685488
   PubMed Web of Science ®Google Scholar
• JacobsJHammerman-RozenbergRCohenAChronic back pain among the elderly: prevalence, associations, and predictorsSpine (Phila Pa 1976)200631E203E20716582841
   PubMed Web of Science ®Google Scholar
• RubinDIEpidemiology and risk factors for spine painNeurol Clin20072535337117445733
   PubMed Web of Science ®Google Scholar
• AnsaniNTStarzTWEffective use of nonsteroidal anti-inflammatory drugsThe Female Patient2002272230
   Google Scholar
• KuritzkyLPain in the ambulatory setting: the role of nonsteroidal anti-inflammatory drugsPrimary Care Special Edition20037912
   Google Scholar
• KuritzkyLA practical approach to low back painYour Patient and Fitness199592225
   Google Scholar
• AmadioPCummingsDMAmadioPBNSAIDs revisitedPostgrad Med19971012572719046939
   PubMed Web of Science ®Google Scholar
• HuangJHuntRHA clinician’s view of strategies for preventing NSAID-induced gastrointestinal ulcersInflammopharmacology199641730
   Google Scholar
• WolfeMMLichtensteinDRSinghGGastrointestinal toxicity of nonsteroidal anti-inflammatory drugsN Engl J Med19993401888189910369853
   PubMed Web of Science ®Google Scholar
• AbramsonSBWeaverALCurrent state of therapy for pain and inflammationArthritis Res Ther20057Suppl 4S1S616168076
   PubMed Web of Science ®Google Scholar
• HooperLBrownTJElliottRAPayneKRobertsCSymmonsDThe effectiveness of fine strategies for the prevention of gastrointestinal toxicity induced by NSAIDs: systematic reviewBMJ200432994815475342
   PubMed Web of Science ®Google Scholar
• WarnerTDGiulianoFVojnovicINonsteroid drug selectivities for cyclooxygenase-1 rather than cyclooxygenase 2 are associated with human gastrointestinal toxicity: a full in vitro analysisProc Natl Acad Sci U S A1999967563756810377455
   PubMed Web of Science ®Google Scholar
• RoelofsPDDeyoRAKoesBWScholtenRJvan TulderMWNon-steroidal anti-inflammatory drugs for low back painCochrane Database Syst Rev20091180
   Google Scholar
• ListerBJPolandMDeLappREEfficacy of nabumetone versus diclofenac, naproxen, ibuprofen, and piroxicam in osteoarthritis and rheumatoid arthritisAm J Med1993952S9S8356999
   PubMedGoogle Scholar
• CannonGWBreedveldFCEfficacy of cyclooxygenase-2 specific inhibitorsAm J Med20011106S12S11173044
   PubMedGoogle Scholar
• PollisonRNonsteroidal anti-inflammatory drugs: practical and theoretical considerations in their selectionAm J Med199610031S36S8604725
   PubMed Web of Science ®Google Scholar
• WeaverARubinBCaldwellJComparison of the efficacy and safety of oxaprozin and nabumetone in the treatment of patients with osteoarthritis of the kneeClin Ther1995177357458565037
   PubMed Web of Science ®Google Scholar
• CaldwellJRCrainDHoffmeisterRTFour-way, multicentre, crossover trial of ibuprofen, fenoprofen calcium, naproxen, and tomeltin sodium in osteoarthritisSouthern Med J1983767067116344227
   PubMed Web of Science ®Google Scholar
• HusbyGHolmeIRugstadHEA double blind multicentre trial of piroxicam and naproxen in osteoarthritisClin Rheumatol1985584913514082
   PubMed Web of Science ®Google Scholar
• BrownBILJohnsonJHHearronMSDouble-blind comparison of flurbiprofen and sulindac for the treatment of osteoarthritisAm J Med198680Suppl 3A1121173515919
   PubMed Web of Science ®Google Scholar
• KolodnyALTwo double-blind trials of diclofenac sodium with aspirin and with naproxen in the treatment of patients with rheumatoid arthritisJ Rheumatol198815120512113054094
   PubMed Web of Science ®Google Scholar
• LaineLGastrointestinal effects of NSAIDs and coxibsJ Pain Symptom Manage20032532S40S
   PubMed Web of Science ®Google Scholar
• GrahamDJCampenDHuiRRisk of acute myocardial infarction and sudden cardiac death in patients treated with cyclo-oxygenase 2 selective and non-selective non-steroidal anti-inflammatory drugs: nested case-control studyLancet200536547548115705456
   PubMed Web of Science ®Google Scholar
• WeaverALCurrent and emerging treatments for mild/moderate acute ambulatory painAm J Ther200815S12S1619127123
   PubMed Web of Science ®Google Scholar
• RothSHBennettREMitchellCSCimetidine therapy in NSAID drug gastropathyArch Intern Med1987147179818013310942
   PubMedGoogle Scholar
• SilversteinFEGrahamDYSeniorJRMisoprostol reduces serious gastrointestinal complications in patients with rheumatoid arthritis receiving nonsteroidal anti-inflammatory drugsAnn Intern Med19951232412497611589
   PubMed Web of Science ®Google Scholar
• SilversteinFEFaichGGoldsteinJLGastrointestinal toxicity with celecoxib vs NSAIDs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. Celecoxib Long-term Arthritis Safety StudyJAMA20002841247125510979111
   PubMed Web of Science ®Google Scholar
• JuniPRutjesAWSDieppePAAre selective COX2 inhibitors superior to traditional NSAIDs? Adequate analysis of the CLASS trial indicates that this may not be the caseBMJ20023241287128812039807
   PubMed Web of Science ®Google Scholar
• DeMariaANWeirMRCoxibs – beyond the GI tract: renal and cardiovascular issuesJ Pain Symptom Manage200325S41S4912604156
   PubMed Web of Science ®Google Scholar
• PerazellaMACOX-2 inhibitors and the kidneyHosp Pract (Minneap)200136434611263799
   PubMed Web of Science ®Google Scholar
• ZhangJDingELSongYAdverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia eventsJAMA20062961619163216968832
   PubMed Web of Science ®Google Scholar
• RadfordMGHolleyKEGrandeJPReversible membranous nephropathy associated with the use of NSAIDsJAMA19962764664698691554
   PubMed Web of Science ®Google Scholar
• CliveDMStoffJSRenal syndromes associated with NSAIDsN Engl J Med19843105635726363936
   PubMed Web of Science ®Google Scholar
• WheltonARenal aspects of treatment with conventional NSAIDs versus cyclooxygenase-2-specific inhibitorsAm J Med2001110Suppl 3A33S42S11173048
   PubMed Web of Science ®Google Scholar
• SolomonSDMcMurrayJJVPfeferMACardiovascular risk associated with celecoxib in a clinical trial for colorectal adenoma preventionN Engl J Med20053521071108015713944
   PubMed Web of Science ®Google Scholar
• FitzGeraldGACoxibs and cardiovascular diseaseN Engl J Med20043511709171115470192
   PubMed Web of Science ®Google Scholar
• Hippisley-CoxJCouplandCRisk of MI in patient taking COX2 inhibitors or conventional NSAIDs: population based nested case-control analysisBMJ20053301366136915947398
   PubMed Web of Science ®Google Scholar
• ZhaoSZBurkeTAWheltonAvon AllmenHHendersonSCBlood pressure destabilization and related healthcare utilization among hypertensive patients using nonspecific NSAIDs and COX2 specific inhibitorsAm J Manag Care20028S401S41412416790
   PubMed Web of Science ®Google Scholar
• McCarbergBHKuritzkyLLow back pain: Identification and managementJ Musculoskelet Med2003SupplS3S21
   Google Scholar
• CaillietRPain: mechanisms, assessment, and managementSoft Tissue Pain and Disability3rd edPhiladelphia, PAFA Davis Co1996
   Google Scholar
• BorensteinDGLacksSWieselSWCyclobenzaprine and naproxen versus naproxen alone in the treatment of acute low back pain and muscle spasmClin Ther1990121251312141299
   PubMed Web of Science ®Google Scholar
• MooreRATramerMRCarrollDQuantitative systematic review of topically applied NSAIDsBMJ19983163333389487165
   PubMed Web of Science ®Google Scholar
• HeynemanCALawless-LidayCWalllGCOral versus topical NSAIDs in rheumatic disease: a comparisonDrugs20006055557411030467
   PubMed Web of Science ®Google Scholar
• RuoffGLemaMStrategies in pain management: new and potential indications for COX-2 specific inhibitorsJ Pain Symptom Manage200325S21S3112604154
   PubMed Web of Science ®Google Scholar
• MalmivaaraAHakiinenUAroTThe treatment of low back painN Engl J Med19953323513557823996
   PubMed Web of Science ®Google Scholar